SCHEMBL11888590

SCHEMBL11888590

O=C(Nc1ccccc1C(=O)O)c1ccc(Br)o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 1.00
▸ HPGD P15428 6/20 1.00
▸ RAB9A P51151 4/20 1.00
▸ NPC1 O15118 2/20 1.00
▸ SMN1; SMN2 Q16637 3/20 0.75
▸ MAPT P10636 5/20 0.68
▸ TSHR P16473 7/20 0.64
▸ MAPK1 P28482 1/20 0.64
▸ MEN1 O00255 3/20 0.63
▸ KMT2A Q03164 3/20 0.63
▸ POLB P06746 1/20 0.63
▸ GAA P10253 3/20 0.62
▸ USP2 O75604 1/20 0.62
▸ KDM4E B2RXH2 2/20 0.60
▸ LMNA P02545 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.58
▸ MAPK10 P53779 2/20 0.58
▸ HTT P42858 1/20 0.58
▸ CSF1R P07333 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8802200 0.84 TSHR (0.84) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL6835903 0.82 ALDH1A1 (0.70) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL3642839 0.79 MAPT (0.88) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL6426650 0.76 KMT2A (0.69) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL15528812 0.75 MAPK1 (0.71) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL2058331 0.75 ALDH1A1 (0.68) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL13701152 0.74 RAB9A (0.74) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL13167004 0.73 ALDH1A1 (1.00) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL414754 0.73 MEN1 (0.83) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL2028671 0.73 DHODH (0.86) ALDH1A1RAB9ANPC1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785499-B2 Targeting NAD biosynthesis in bacterial pathogens UNIVERSITY OF MARYLAND, BALTIMORE (US) 2014-07-22 — — US disclosed
US-20120190708-A1 TARGETING NAD BIOSYNTHESIS IN BACTERIAL PATHOGENS UNIVERSITY OF MARYLAND, BALTIMORE (US) 2012-07-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190708-A1 TARGETING NAD BIOSYNTHESIS IN BACTERIAL PATHOGENS NAMPT, NAPRT, NADK ALDH1A1 1536/4885HPGD 66/4885RAB9A 2191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback